Browse > Article
http://dx.doi.org/10.7730/JSCM.2014.26.2.165

Neuroprotective Effects of Hyangsayangwi-tang in MPTP-induced Mouse Model of Parkinson's Disease  

Go, Ga-Yeon (Dept. of Sasang Constitutional Medicine, College of Oriental Medicine, Daejeon university)
Kim, Yun-Hee (Dept. of Sasang Constitutional Medicine, College of Oriental Medicine, Daejeon university)
Ahn, Taek-Won (Dept. of Sasang Constitutional Medicine, College of Oriental Medicine, Daejeon university)
Publication Information
Journal of Sasang Constitutional Medicine / v.26, no.2, 2014 , pp. 165-179 More about this Journal
Abstract
Objectives To evaluate the neuroprotective effects of Hyangsayangwi-tang (HY), a Korean traditional medicinal prescription in a Parkinson's disease mouse model. Methods Four groups(each of 10 mouse per group) were used in this study. The neuroprotective effect of HY was examined in a Parkinson's disease mouse model. C57BL/6 mouse treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, 30mg/kg/day), intraperitoneal (i.p.) for 5 days. Slow behavioral responses and memory disorder is the major clinical symptoms of PD. In order to investigate the effect of HY on recovery of behavioral deficits and memory, we examined the motor function and memory by using Morris water maze and Forced swimming test. Ischemic mouse brain stained with TTC(2,3,5 triphenyl tetrazolium chloride) in the MPTP-induced Parkinson's disease to find out ischemia and tissue damage in mouse. The convenient, simple, and accurate high-performance liquid chromatography (HPLC) method was established for simultaneous determination of neurotransmitters in MPTP-HY group. To measure the amount of dopamine in mice brain, striatum-substantia nigra, was examined by Bradford assay. Immunohistochemistry was examined in the MPTP-induced Parkinson's disease (PD) mouse to evaluate the neuroprotective effects of Hyangsayangwi-tang on hippocampal lesion, ST and SNpc. Results and Conclusions Hyangsayangwi-tang (HY) prevents MPTP-induced loss of serotonin, hippocampus and TH-ir cell.
Keywords
Hyangsayangwi-tang; Parkinson's disease; Serotonin; Hippocampus; TH-ir cell;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, et al. Corticotropin releasing factor receptor 1-deficient micedisplay decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron. 1998;20(6):1093-102.   DOI   ScienceOn
2 Porsolt RD. Animal model of depression. Biomedicine 1979;30:139-140.
3 Arai N, Isaji M, Kojima M, Mizuta E, Kuno S. Combined effects of cabergoline and L-dopa on parkinsonism in MPTP-treated cynomolgus monkeys. J Neural Transmission 103(11):1037-1316, 1996.
4 Lau, Y.S., Meredith, G.E. From drugs of abuse to parkinsonism: The MPTP Mouse Model of Parkinson's Disease. Methods in Molecular Medicine 79(1): 103-116, 2003.
5 Lee JM. Dongeuisoosebowonsasangbonchokwon. Seoul: Eulyumoonhwasa. 2002:27-278. (Korean)
6 The National College of Oriental Medicine Sasangeuihakclassroom. Sasangeuihak. Seoul: Jipmundang. 2004: 260,265,276,394-5,442-80. (Korean)
7 Song IB et all. Sasangeuihak. Seoul:Jipmundang. 2004:343,366. (Korean)
8 Lee JC. Sinsasangeuihakron II. Seoul:Mokkwato. 2001:79-83. (Korean)
9 Jeong BJ, Kim JW, Kim BC, Woo SH, Na YJ, Shin HJ et al. A case of tremor in Parkinson's disease treated with Korean medicine. Korean J. Orient.int.Med. 2006:27(4)954-961. (Korean)
10 Bae NY. Neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement on Parkinsonian model. Dae-jeon National University. 2013;25(3):208-217. (Korean)
11 Brian R. Perri, Douglas H. Smith, Hisayuki Murai, Grant Sinson, Kathryn E. Saatman, Ramesh Raghupathl, Raymond T. Bartus, Tracy K. Mcintosh. Metabolic Quantification of Lesion Volume following Experimental Traumatic Brain Injury in the Rat. Journal of Neurotrauma. 1997;14:15-22.   DOI   ScienceOn
12 Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron. 2003;39:889-909.   DOI   ScienceOn
13 Imaki T, Katsumata H, Miyata M, Naruse M, Imaki J, Minami S. Expression of corticotropin-releasing hormone type 1 receptor in paraventricular nucleus after acute stress. Neuroendocrinology. 2001;73(5):293-301.   DOI   ScienceOn
14 Bae NY, Yang HO, Ahn TW. Protection effect of New-Yeolda-Hanso tang $against\beta$-Amyloid Induced Cytotoxicity in NGF-differentiated PC12 Cells. J Sasang Constitut Med. 2009;21:138-153. (Korean)   과학기술학회마을
15 Bae NY, Ahn TK, Chung SK, Oh MS, Ko HS, Oh HG et al. The neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement in modelsof Parkinson's disease. Journal of Ethnopharmacology. 2011;134:313-322. (Korean)   DOI   ScienceOn
16 Seo JH, Shin MS, Kim CJ, Lee KS, lim BB. The influence of treadmill exercise in hot environments about serotonin expression in the rat brain, generating neurons and short-term memory. Korean Journal of Sport Science. 2009;20(4);744. (Korean)
17 Ferger, B., Teismann, P., Earl, C,D., Kuschinsky, K., Oertel, W.H. The propective effects of PBN against MPTP toxocity are independent of hydroxyl radical trapping. Phamaco Biochem Behav. 2000;65(3): 425-431.   DOI   ScienceOn
18 Vosselera M., N. Abegunewardenea, N. Hoffmannb, S.E. Petersene, D. Beckera, D. Cleppienb, P. Kunzc, K.-F. Kreitnerc, M. Lauterbacha, B. Bierbachd, C. Duberc, T. Goria, T. Munzela, L.M. Schreiberb, G. Horsticka. Area at Risk and Viability after Myocardial Ischemia and Reperfusion Can Be Determined by Contrast-Enhanced Cardiac Magnetic Resonance Imaging. Eur Surg Res. 2009;43:13-23.   DOI   ScienceOn
19 Widdowson, P.S., Farnworth, M.J., Upton, R., Simpson, M.G. No changes in behavior, nigro-striatal system neurochemistry or neuronal cell death following toxic multiple oral paraquat administration to rat. Human and Experomental Toxicology. 1996; 15(7):583-591.   DOI   ScienceOn
20 Westm B.D., Sheghrue, P.J., Vanko, A.E.H,, Ransorn, R.W. Kinney, G.G. Amphetamine-induced locomotor activity is reduced in mice following MPTP treatment but not following selegiline/MPTP treatment. Pharmacol. Biochm. Behav 2006;84(1):158-161.   DOI
21 Sun, L., Xu, S., Zhou, M., Wang, C., Wu, Y., Chan, P. Effects of cysteamine on MPTP-induced dopaminergic neurodegeneration in mice. Brain Research. 2010;1335:74-82.   DOI
22 Fetoni V, Soliveri P, Monza D, Testa D, Girotti F. Affective symptoms in multiple system atropy and Parkinson's disease : response to levodopa therapy. J Neurol Neurosurg Psychiatry. 1999;66:541-544.   DOI
23 Burn DJ. Depression in Parkinson's disease. Eur J Neurol 9. 2002:44-54.   DOI
24 Porsolt RD, Anton G, Blavet N et al. Behavioral despair in rats : A new model sensitive to antidepressant treatments. Eur J Pharmacol 1978;47:379-391.   DOI   ScienceOn
25 Langston, J.W., Irwin, I., Langston, E.B., Forno, L.S. Pargyline prevents MPTP-induced parkinsonism in primates. Science 225(4669):1460-1462, 1984.   DOI
26 Cummings JL. Depression in Parkinson's disease : a review. Am J Psychiatry 1992;149:443-454.   DOI
27 Kasper, Braunwald, Fauci, Hauser, Longo, Jameson. Harrison's Principles of Internal medicine. 16th edition. Seoul: MIP. 2006:2631-2638.